MEDPMedpace Holdings, Inc.同业对比
Medpace Holdings, Inc. 与iShares Biotechnology ETF 持仓的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:IBB 前十大持仓| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDP本股 | $18.2B#14 | 36.2x#5 | 31.2x#10 | 7.2x#6 | 20.0%#7 | 11.6%#10 | 21.1%#8 | 77.1%#1 | — | — | 12.5%#5 | — |
| VRTX | $141.7B#4 | 32.6x#4 | 7.0x#4 | 11.8x#8 | 8.9%#9 | 838.1%#3 | 34.8%#2 | 19.5%#6 | 25.0%#4 | — | 33.1%#3 | — |
| AMGN | $252.0B#2 | 29.0x#3 | 21.6x#9 | 6.9x#4 | 10.0%#8 | 88.5%#7 | 24.7%#7 | 66.0%#2 | 15.1%#7 | — | 62.9%#1 | 2.0%#1 |
| GILD | $212.0B#3 | — | 16.3x#8 | 7.2x#5 | 2.4%#10 | 1672.9%#2 | 34.0%#3 | 65.3%#3 | 25.7%#3 | — | — | 1.9%#2 |
| REGN | — | 20.5x#2 | — | — | 1.0%#12 | 2.1%#11 | 24.9%#6 | 13.4%#7 | 9.2%#9 | — | 41.7%#2 | — |
| ARGX | $55.2B#7 | — | — | 1554.5x#13 | 254.4%#1 | 55.1%#8 | 2965.7%#1 | — | — | — | — | — |
| ALNY | $22.1B#13 | 8.6x#1 | 6.1x#3 | 5.9x#3 | 65.2%#3 | 212.8%#4 | 13.5%#10 | 8.7%#9 | 19.3%#6 | — | -63.3%#7 | — |
| NTRA | $59.7B#6 | — | 32.8x#11 | 25.9x#9 | 35.9%#5 | -9.3%#12 | -13.4%#12 | -11.4%#11 | -18.0%#10 | — | — | — |
| RVMD | $41.0B#8 | — | 15.7x#7 | — | — | -88.5%#15 | — | -43.4%#13 | — | — | — | — |
| BIIB | $37.5B#9 | 109.8x#8 | 2.5x#1 | 3.8x#1 | 2.2%#11 | -20.8%#13 | 28.7%#5 | 8.7%#8 | 12.3%#8 | 3#3 | — | — |
| ILMN | $35.7B#10 | 40.6x#6 | 11.3x#5 | 8.2x#7 | -0.7%#13 | 169.5%#5 | 18.6%#9 | 27.0%#4 | 19.9%#5 | 8#1 | — | — |
| MRNA | $88.5B#5 | — | 13.1x#6 | 45.5x#11 | -39.9%#14 | 20.8%#9 | -158.1%#13 | -41.7%#12 | -54.6%#11 | — | — | — |
| INSM | $24.7B#11 | — | 34.0x#12 | 40.7x#10 | 66.7%#2 | -39.7%#14 | -205.6%#14 | -175.8%#14 | -141.2%#12 | 3#3 | -42.0%#6 | — |
| ONC | $547.3B#1 | 861.1x#9 | 105.8x#13 | 102.4x#12 | 40.2%#4 | 144.5%#6 | 8.4%#11 | 5.5%#10 | 29.9%#2 | 6#2 | — | — |
| INCY | $24.5B#12 | 61.4x#7 | 4.3x#2 | 4.8x#2 | 21.2%#6 | 3846.9%#1 | 29.5%#4 | 22.8%#5 | 45.1%#1 | — | 30.0%#4 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-02。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议